Tariffs, funding cuts threaten the ecosystem of companies and research institutes that have made the Commonwealth a biotech ...

Eli Lilly's weight-loss and diabetes drug, Mounjaro, has rapidly gained popularity in India, achieving Rs 24 crore in sales ...

A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

Stem cells can fight disease from the inside out. But spas and clinics are selling treatments that are unproven, expensive, ...

Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...

The Federal Circuit recently considered the scope of a permanent injunction that prohibited a drug manufacturer from ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

Ivarmacitinib, also known as oral SHR0302, is not yet approved by the FDA, with trials currently exploring its utility in ...

A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...

The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital are collaborating to launch the Kinder ...

Below is a list of U.S. regulators who oversee Musk's companies, including automaker Tesla, rocket and satellite company ...